{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:25:46Z","timestamp":1793298346488,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01022-x","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:52:06Z","timestamp":1762959126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of SLCO1B1 (rs2306283) polymorphism on personalized atorvastatin dosing in a genetically distinct South Asian cohort"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1496-0490","authenticated-orcid":false,"given":"Tayaba","family":"Farooq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6636-152X","authenticated-orcid":false,"given":"Uzma","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8557-9140","authenticated-orcid":false,"given":"Afifa","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3127-2219","authenticated-orcid":false,"given":"Samia","family":"Kausar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7295-7950","authenticated-orcid":false,"given":"Akbar","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5036-5233","authenticated-orcid":false,"given":"Sidra","family":"Mumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"1022_CR1","unstructured":"Pappan N, Rehman A, Dyslipidemia D. 2022 [cited 2025 May 18]. pp. 1\u20135. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560891\/"},{"issue":"1","key":"1022_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-020-01204-y","volume":"19","author":"M Hedayatnia","year":"2020","unstructured":"Hedayatnia M, Asadi Z, Zare-Feyzabadi R, Yaghooti-Khorasani M, Ghazizadeh H, Ghaffarian-Zirak R, et al. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis. 2020;19(1):1\u201311.","journal-title":"Lipids Health Dis"},{"key":"1022_CR3","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019. (GBD 2019) Reference Life Table [Internet]. Institute for Health Metrics and Evaluation (IHME). 2021. Available from: https:\/\/ghdx.healthdata.org\/record\/ihme-data\/global-burden-disease-study-2019-gbd-2019-reference-life-table"},{"issue":"17","key":"1022_CR4","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1161\/CIRCULATIONAHA.122.059122","volume":"147","author":"Z Samad","year":"2023","unstructured":"Samad Z, Hanif B. Cardiovascular diseases in pakistan: imagining a postpandemic. Postconflict Future Circulation. 2023;147(17):1261\u20133.","journal-title":"Postconflict Future Circulation"},{"issue":"9","key":"1022_CR5","doi-asserted-by":"publisher","first-page":"e7239","DOI":"10.1590\/1414-431x20187239","volume":"51","author":"M Zaid","year":"2018","unstructured":"Zaid M, Hasnain S. Plasma lipid abnormalities in Pakistani population: Trends, associated factors, and clinical implications. Brazilian J Med Biol Res. 2018;51(9):e7239.","journal-title":"Brazilian J Med Biol Res"},{"issue":"2","key":"1022_CR6","first-page":"45","volume":"59","author":"N Naeem","year":"2020","unstructured":"Naeem N, Butt A, Zafar A, Bin, Fawwad A, Tahir B, Basit A. Dyslipidemia pattern among newly diagnosed and known type 2 diabetics: A comparative analysis from a tertiary care hospital of Karachi, Pakistan. Pak J Med Res. 2020;59(2):45\u201350.","journal-title":"Pak J Med Res"},{"key":"1022_CR7","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol [Internet]. 2019 Jun 25 [cited 2025 Sep 9];73(24):3168\u2013209. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30423391\/"},{"issue":"11","key":"1022_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/gim.2014.41","volume":"16","author":"WJ Canestaro","year":"2014","unstructured":"Canestaro WJ, Austin MA, Thummel KE. Genetic factors affecting Statin concentrations and subsequent myopathy: a hugenet systematic review. Genet Med. 2014;16(11):810\u20139.","journal-title":"Genet Med"},{"key":"1022_CR9","unstructured":"Karen W, Richard F, Thomas PA. In: Richard HA, editor. Lippincott\u2019s illustrated reviews: Pharmacology. 6 ed. Lippincott Williams & Wilkins; 2015. p. 664."},{"key":"1022_CR10","unstructured":"Talreja O, Kerndt CC, Cassagnol M. Simvastatin [Internet]. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25920750"},{"issue":"11","key":"1022_CR11","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1345\/aph.1A413","volume":"36","author":"S de Denus","year":"2002","unstructured":"de Denus S, Spinler SA. Early Statin therapy for acute coronary syndromes. Ann Pharmacother. 2002;36(11):1749\u201358.","journal-title":"Ann Pharmacother"},{"key":"1022_CR12","unstructured":"Bertram K, Anthony T. Basic and clinical Pharmacology Katzung. 15th ed. McGraw Hill\/Medical; 2020. p. 1328."},{"issue":"5","key":"1022_CR13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.2165\/00003495-199753050-00011","volume":"53","author":"AP Lea","year":"1997","unstructured":"Lea AP, McTavish D, Atorvastatin. A review of its Pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997;53(5):828\u201347.","journal-title":"Drugs"},{"key":"1022_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1155\/2020\/3987065","volume":"2020","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xing L, Jia X, Pang X, Xiang Q, Zhao X, et al. Comparative Lipid-Lowering\/Increasing efficacy of 7 Statins in patients with Dyslipidemia, cardiovascular Diseases, or diabetes mellitus: systematic review and network Meta-Analyses of 50 randomized controlled trials. Cardiovasc Ther. 2020;2020:21.","journal-title":"Cardiovasc Ther"},{"issue":"12","key":"1022_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2217\/pgs-2022-0044","volume":"23","author":"G Bharath","year":"2022","unstructured":"Bharath G, Vishnuprabu DP, Preethi L, Nagappan AS, Dhianeshwaran Isravanya RT, Bhaskar LVKS, et al. SLCO1B1 and ABCB1 variants synergistically influence the Atorvastatin treatment response in South Indian coronary artery disease patients. Pharmacogenomics. 2022;23(12):683\u201394.","journal-title":"Pharmacogenomics"},{"key":"1022_CR16","doi-asserted-by":"publisher","first-page":"575678","DOI":"10.3389\/fgene.2020.575678","volume":"11","author":"PS Kee","year":"2020","unstructured":"Kee PS, Chin PKL, Kennedy MA, Maggo SDS. Pharmacogenetics of Statin-Induced myotoxicity. Front Genet. 2020;11:575678.","journal-title":"Front Genet"},{"key":"1022_CR17","unstructured":"SLCO2A1 solute carrier organic. anion transporter family, member 2A1 [Homo sapiens] - Gene result [Internet]. [cited 2024 Aug 27]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/10599"},{"issue":"1","key":"1022_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/ijms18010104","volume":"18","author":"E Arrigoni","year":"2017","unstructured":"Arrigoni E, Del Re M, Fidilio L, Fogli S, Danesi R, Di Paolo A. Pharmacogenetic foundations of therapeutic efficacy and adverse events of Statins. Int J Mol Sci. 2017;18(1):104.","journal-title":"Int J Mol Sci"},{"key":"1022_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3389\/fphar.2020.00728","volume":"11","author":"C Na Nakorn","year":"2020","unstructured":"Na Nakorn C, Waisayarat J, Dejthevaporn C, Srisawasdi P, Wongwaisayawan S, Sukasem C. Genetic variations and frequencies of the two functional single nucleotide polymorphisms of SLCO1B1 in the Thai population. Front Pharmacol. 2020;11:728.","journal-title":"Front Pharmacol"},{"key":"1022_CR20","doi-asserted-by":"crossref","unstructured":"Goljan E, Abouelhoda M, Tahir A, ElKalioby M, Meyer B, Monies D. Large-scale next generation sequencing based analysis of SLCO1B1 pharmacogenetics variants in the Saudi population. Hum Genomics [Internet]. 2024 Dec 1 [cited 2025 Sep 9];18(1):30. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10962151\/","DOI":"10.1186\/s40246-024-00594-9"},{"issue":"5","key":"1022_CR21","first-page":"288","volume":"72","author":"K Mladenovska","year":"2017","unstructured":"Mladenovska K, Daka Grapci A, Vavlukis M, Kapedanovska A, Eftimov A, Matevska Geshkovska N, et al. Influence of SLCO1B1 polymorphisms on Atorvastatin efficacy and safety in Macedonian subjects. Pharmazie. 2017;72(5):288\u201395.","journal-title":"Pharmazie"},{"issue":"8","key":"1022_CR22","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.3390\/ijms21082884","volume":"21","author":"JJG Marin","year":"2020","unstructured":"Marin JJG, Serrano MA, Monte MJ, Sanchez-Martin A, Temprano AG, Briz O, et al. Role of genetic variations in the hepatic handling of drugs. Int J Mol Sci. 2020;21(8):2884.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1022_CR23","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.3390\/ijms12095815","volume":"12","author":"AC Rodrigues","year":"2011","unstructured":"Rodrigues AC, Perin PMS, Purim SG, Silbiger VN, Genvigir FDV, Willrich MAV, et al. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388a\u2009>\u2009G variant is determinant of increased Atorvastatin response. Int J Mol Sci. 2011;12(9):5815\u201327.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1022_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1574884715666200827105612","volume":"16","author":"ZM Shahrure","year":"2021","unstructured":"Shahrure ZM, Irshaid YM, Mustafa KN, Abujbara MA, Shhab M, Al, El-Khateeb MS, et al. Slco1b1 gene polymorphisms (Rs2306283 and rs4149056) and statin-induced myopathy in Jordanian diabetics. Curr Rev Clin Exp Pharmacol. 2021;16(3):281\u20138.","journal-title":"Curr Rev Clin Exp Pharmacol"},{"key":"1022_CR25","doi-asserted-by":"crossref","unstructured":"DeGorter MK, Tirona RG, Schwarz UI, Choi YH, Dresser GK, Suskin N, et al. Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care. Circ Cardiovasc Genet [Internet]. 2013;6(4):400\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23876492\/","DOI":"10.1161\/CIRCGENETICS.113.000099"},{"key":"1022_CR26","doi-asserted-by":"crossref","unstructured":"Ramsey LB, Johnson SG, Caudle KE, Haidar CE, Voora D, Wilke RA, et al. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and Simvastatin-Induced myopathy: 2014 update. Clinical Pharmacology and Therapeutics. Volume 96. Nature Publishing Group; 2014. pp. 423\u20138.","DOI":"10.1038\/clpt.2014.125"},{"key":"1022_CR27","unstructured":"rs2306283 RefSNP. Report - dbSNP - NCBI [Internet]. [cited 2025 Jun 12]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs2306283\/"},{"issue":"2","key":"1022_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng1706","volume":"38","author":"AD Skol","year":"2006","unstructured":"Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38(2):209\u201313.","journal-title":"Nat Genet"},{"key":"1022_CR29","doi-asserted-by":"crossref","unstructured":"Johnson JL, Abecasis GR. GAS Power Calculator: web-based power calculator for genetic association studies. bioRxiv. 2017;(1973):164343.","DOI":"10.1101\/164343"},{"issue":"2","key":"1022_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5808\/GI.2012.10.2.117","volume":"10","author":"EP Hong","year":"2012","unstructured":"Hong EP, Park JW. Sample size and statistical power calculation in genetic association studies. Genomics Inf. 2012;10(2):117.","journal-title":"Genomics Inf"},{"issue":"9","key":"1022_CR31","doi-asserted-by":"publisher","first-page":"20609","DOI":"10.3390\/ijms160920609","volume":"16","author":"Y Prado","year":"2015","unstructured":"Prado Y, Saavedra N, Zambrano T, Lagos J, Rosales A, Salazar LA. SLCO1B1 c.388A\u2009>\u2009G polymorphism is associated with HDL-C levels in response to Atorvastatin in Chilean individuals. Int J Mol Sci. 2015;16(9):20609\u201319.","journal-title":"Int J Mol Sci"},{"key":"1022_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cca.2013.03.007","volume":"421","author":"MAV Willrich","year":"2013","unstructured":"Willrich MAV, Rodrigues AC, Cerda A, Genvigir FDV, Arazi SS, Dorea EL, et al. Effects of Atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients. Clin Chim Acta. 2013;421:157\u201363.","journal-title":"Clin Chim Acta"},{"key":"1022_CR33","doi-asserted-by":"publisher","unstructured":"Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract [Internet]. 2017;23(April):1\u201387. Available from: https:\/\/doi.org\/10.4158\/EP171764.APPGL","DOI":"10.4158\/EP171764.APPGL"},{"key":"1022_CR34","doi-asserted-by":"crossref","unstructured":"Firnhaber JM. Hyperlipidemia management: a calibrated approach. J Fam Pract. 2023;72(3).","DOI":"10.12788\/jfp.0576"},{"issue":"10","key":"1022_CR35","first-page":"4708","volume":"27","author":"M Zakria","year":"2023","unstructured":"Zakria M, Hussain A, Ahmad N, Ahmed N, Rauf MA, Siraj S. The lipid-lowering efficacy of Rosuvastatin is associated with variations in SLCO1B1: a 12-month prospective cohort study. Eur Rev Med Pharmacol Sci. 2023;27(10):4708\u201317.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1022_CR36","unstructured":"Fariduddin MM, Bansal N. Hypothyroid myopathy. StatPearls. StatPearls Publishing; 2022."},{"issue":"6","key":"1022_CR37","first-page":"441","volume":"17","author":"TA Rajput","year":"2014","unstructured":"Rajput TA, Khaliq Naveed A, Khan S, Farooqi ZUR, Naveed AK, Khan S, et al. Frequencies of two functionally significant SNPs and their haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in six ethnic groups of Pakistani population. Iran J Basic Med Sci. 2014;17(6):441.","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"1022_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10557-017-6723-4","volume":"31","author":"RS Rosenson","year":"2017","unstructured":"Rosenson RS, Miller K, Bayliss M, Sanchez RJ, Baccara-Dinet MT, Chibedi-De-Roche D, et al. The Statin-Associated muscle symptom clinical index (SAMS-CI): revision for clinical Use, content Validation, and Inter-rater reliability. Cardiovasc Drugs Ther. 2017;31(2):179\u201386.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1022_CR39","doi-asserted-by":"crossref","unstructured":"Singh UA, Kumari M, Iyengar S. Method for improving the quality of genomic DNA obtained from minute quantities of tissue and blood samples using Chelex 100 resin. Biol Proced Online [Internet]. 2018 Jun 1 [cited 2024 Aug 22];20(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29881330\/","DOI":"10.1186\/s12575-018-0077-6"},{"key":"1022_CR40","doi-asserted-by":"crossref","unstructured":"Lim DH, Jee H, Moon KC, Lim CS, Jang WS. Development of a simple DNA extraction method and candida pan loop-mediated isothermal amplification assay for diagnosis of candidemia. Pathogens [Internet]. 2022;11(2). Available from: https:\/\/pmc\/articles\/PMC8878442\/.","DOI":"10.3390\/pathogens11020111"},{"key":"1022_CR41","doi-asserted-by":"crossref","unstructured":"Darroudi S, Tayefi MS, karimian M, Motamedzadeh A, Seyed T, Reza M, Mohsen S, et al. Prevalence of combined and noncombined dyslipidemia in an Iranian population. 2018;(May):1\u20137.","DOI":"10.1002\/jcla.22579"},{"key":"1022_CR42","unstructured":"WHO. Noncommunicable diseases: Risk factors [Internet]. World Health Organization. 2021 [cited 2024 Aug 22]. p. 1. Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/ncd-risk-factors"},{"key":"1022_CR43","doi-asserted-by":"crossref","unstructured":"Zhang H, Kwapong WR, Shao MM, Yan JY, Lin X, Da, Chen BB et al. Predictors of the prevalence of dyslipidemia and influencing factors for young health examination cohort: a cross-sectional survey. Front Public Heal. 2020;8.","DOI":"10.3389\/fpubh.2020.00400"},{"key":"1022_CR44","doi-asserted-by":"publisher","unstructured":"Nikparvar M, Khaladeh M, Yousefi H, Vahidi Farashah M, Moayedi B, Kheirandish M. Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey. Sci Rep [Internet]. 2021;11(1):1\u201311. Available from: https:\/\/doi.org\/10.1038\/s41598-021-88680-z","DOI":"10.1038\/s41598-021-88680-z"},{"key":"1022_CR45","doi-asserted-by":"crossref","unstructured":"Phan BAP, Toth PP. Dyslipidemia in women: etiology and management. Int J Womens Health [Internet]. 2014;6(1):185\u201394. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3923614\/","DOI":"10.2147\/IJWH.S38133"},{"issue":"6","key":"1022_CR46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00228-007-0285-5","volume":"63","author":"SR Jada","year":"2007","unstructured":"Jada SR, Xiaochen S, Yan LY, Xiaoqiang X, Lal S, Zhou SF, et al. Pharmacogenetics of SLCO1B1: Haplotypes, HtSNPs and hepatic expression in three distinct Asian populations. Eur J Clin Pharmacol. 2007;63(6):555\u201363.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"1022_CR47","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1007\/s11033-014-3334-z","volume":"41","author":"E Giannakopoulou","year":"2014","unstructured":"Giannakopoulou E, Ragia G, Kolovou V, Tavridou A, Tselepis AD, Elisaf M, et al. No impact of SLCO1B1 521T\u2009>\u2009C, 388A\u2009>\u2009G and 411G\u2009>\u2009A polymorphisms on response to Statin therapy in the Greek population. Mol Biol Rep. 2014;41(7):4631\u20138.","journal-title":"Mol Biol Rep"},{"key":"1022_CR48","doi-asserted-by":"crossref","unstructured":"Sabokbar T, Sharifipour E, Zamanlu M, Komeili Movahhed T, Aghaali M, Salarvand M, et al. Gender differences in response to statin therapy in ischemic stroke patients with SLCO1B1 388A\u2009>\u2009G polymorphism: a clinical study. Biomed Res Bull [Internet]. 2023;1(3):96\u2013104. Available from: https:\/\/typeset.io\/papers\/gender-differences-in-response-to-statin-therapy-in-ischemic-4r3m5erhbm","DOI":"10.34172\/biomedrb.2023.19"},{"issue":"4","key":"1022_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/FPC.0000000000000490","volume":"33","author":"HH Nguyen","year":"2023","unstructured":"Nguyen HH, Nguyen CTT, Mai TNP, Huong PT. Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis. Pharmacogenet Genomics. 2023;33(4):65\u201378.","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"1022_CR50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00228-014-1661-6","volume":"70","author":"M Ferrari","year":"2014","unstructured":"Ferrari M, Guasti L, Maresca A, Mirabile M, Contini S, Grandi AM, et al. Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2. Eur J Clin Pharmacol. 2014;70(5):539\u201347.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9suppl","key":"1022_CR51","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1177\/1076029618805863","volume":"24","author":"X Wu","year":"2018","unstructured":"Wu X, Gong C, Weinstock J, Cheng J, Hu S, Venners SA, et al. Associations of the SLCO1B1 polymorphisms with hepatic Function, baseline lipid Levels, and lipid-lowering response to Simvastatin in patients with hyperlipidemia. Clin Appl Thromb. 2018;24(9suppl):S240\u20137.","journal-title":"Clin Appl Thromb"},{"key":"1022_CR52","doi-asserted-by":"publisher","unstructured":"Abed W, Abujbara M, Batieha A, Ajlouni K. Statin induced myopathy among patients attending the national center for diabetes, endocrinology, & genetics. Ann Med Surg [Internet]. 2022;74(November 2021):103304. Available from: https:\/\/doi.org\/10.1016\/j.amsu.2022.103304","DOI":"10.1016\/j.amsu.2022.103304"},{"issue":"4","key":"1022_CR53","doi-asserted-by":"publisher","first-page":"504","DOI":"10.4103\/ijem.IJEM_79_17","volume":"21","author":"K Manoj","year":"2017","unstructured":"Manoj K, Jain N, Madhu SV. Myopathy in patients taking atorvastatin: A pilot study. Indian J Endocrinol Metab. 2017;21(4):504\u20139.","journal-title":"Indian J Endocrinol Metab"},{"key":"1022_CR54","doi-asserted-by":"publisher","unstructured":"Skilving I, Eriksson M, Rane A, Ovesj\u00f6 ML. Statin-induced myopathy in a usual care setting\u2014a prospective observational study of gender differences. Eur J Clin Pharmacol [Internet]. 2016;72(10):1171\u20136. Available from: https:\/\/doi.org\/10.1007\/s00228-016-2105-2","DOI":"10.1007\/s00228-016-2105-2"},{"issue":"2","key":"1022_CR55","first-page":"617","volume":"31","author":"S Sadeeqa","year":"2018","unstructured":"Sadeeqa S, Maqsood M, Ahmad M. Prevalence of Statin induced myopathy in Lahore, Pakistan. Pak J Pharm Sci. 2018;31(2):617\u201322.","journal-title":"Pak J Pharm Sci"},{"issue":"8","key":"1022_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCOUTCOMES.118.005562","volume":"12","author":"MG Nanna","year":"2019","unstructured":"Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, et al. Sex differences in the use of Statins in community practice: patient and provider assessment of lipid management registry. Circ Cardiovasc Qual Outcomes. 2019;12(8):1\u201310.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"1022_CR57","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/clpt.2010.255","volume":"89","author":"LA Donnelly","year":"2011","unstructured":"Donnelly LA, Doney ASF, Tavendale R, Lang CC, Pearson ER, Colhoun HM, et al. Common nonsynonymous substitutions in SLCO1B1 predispose to Statin intolerance in routinely treated individuals with type 2 diabetes: A Go-DARTS study. Clin Pharmacol Ther. 2011;89(2):210\u20136.","journal-title":"Clin Pharmacol Ther"},{"key":"1022_CR58","doi-asserted-by":"crossref","unstructured":"Stewart A. SLCO1B1 polymorphisms and statin-induced myopathy. plos curr. Dec 2013.","DOI":"10.1371\/currents.eogt.d21e7f0c58463571bb0d9d3a19b82203"},{"key":"1022_CR59","doi-asserted-by":"crossref","unstructured":"Jiang J, Tang Q, Feng J, Dai R, Wang Y, Yang Y, et al. Association between SLCO1B1 \u2013\u2009521T\u2009>\u2009C and \u2013\u2009388A\u2009>\u2009G polymorphisms and risk of statin-induced adverse drug reactions: a meta-analysis. Springerplus. 2016;5(1).","DOI":"10.1186\/s40064-016-2912-z"},{"issue":"3","key":"1022_CR60","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41397-021-00208-w","volume":"21","author":"S Turongkaravee","year":"2021","unstructured":"Turongkaravee S, Jittikoon J, Lukkunaprasit T, Sangroongruangsri S, Chaikledkaew U, Thakkinstian A. A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy. Pharmacogenomics J. 2021;21(3):296\u2013307.","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"1022_CR61","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00228-011-1125-1","volume":"68","author":"PCJL Santos","year":"2012","unstructured":"Santos PCJL, Gagliardi ACM, Miname MH, Chacra AP, Santos RD, Krieger JE, et al. SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with Familial hypercholesterolemia. Eur J Clin Pharmacol. 2012;68(3):273\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"17","key":"1022_CR62","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","volume":"36","author":"ES Stroes","year":"2015","unstructured":"Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin-associated muscle symptoms: impact on Statin therapy - European atherosclerosis society consensus panel statement on Assessment, aetiology and management. Eur Heart J. 2015;36(17):1012\u201322.","journal-title":"Eur Heart J"},{"key":"1022_CR63","doi-asserted-by":"crossref","unstructured":"Vinci P, Panizon E, Tosoni LM, Cerrato C, Pellicori F, Mearelli F, et al. Statin-associated myopathy: emphasis on mechanisms and targeted therapy. Int J Mol Sci. 2021;22(21).","DOI":"10.3390\/ijms222111687"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01022-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:52:24Z","timestamp":1762959144000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-01022-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01022-x","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board (IRB) of Islamic International Medical College, Riphah International University (Reference No: Riphah\/IRC\/23\/3114). Prior to enrolment, all participants provided written informed consent, following the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}